Correlation Between Pfizer and Columbia Trarian
Can any of the company-specific risk be diversified away by investing in both Pfizer and Columbia Trarian at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Columbia Trarian into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Columbia Trarian E, you can compare the effects of market volatilities on Pfizer and Columbia Trarian and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Columbia Trarian. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Columbia Trarian.
Diversification Opportunities for Pfizer and Columbia Trarian
-0.88 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pfizer and Columbia is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Columbia Trarian E in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Columbia Trarian E and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Columbia Trarian. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Columbia Trarian E has no effect on the direction of Pfizer i.e., Pfizer and Columbia Trarian go up and down completely randomly.
Pair Corralation between Pfizer and Columbia Trarian
If you would invest 2,945 in Columbia Trarian E on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Columbia Trarian E or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 1.56% |
Values | Daily Returns |
Pfizer Inc vs. Columbia Trarian E
Performance |
Timeline |
Pfizer Inc |
Columbia Trarian E |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pfizer and Columbia Trarian Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Columbia Trarian
The main advantage of trading using opposite Pfizer and Columbia Trarian positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Columbia Trarian can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Columbia Trarian will offset losses from the drop in Columbia Trarian's long position.Pfizer vs. Victory Integrity Smallmid Cap | Pfizer vs. Hilton Worldwide Holdings | Pfizer vs. NVIDIA | Pfizer vs. JPMorgan Chase Co |
Columbia Trarian vs. Columbia Trarian Core | Columbia Trarian vs. Buffalo Large Cap | Columbia Trarian vs. Invesco Disciplined Equity |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data |